On May 26, 2020 MEI Pharma, Inc. (NASDAQ: MEIP) ("MEI"), a late-stage pharmaceutical company focused on advancing new therapies for cancer, reported that it will host an investor and analyst video webcast event on Tuesday, June 2nd, 2020 at 8:00 AM ET following the ASCO (Free ASCO Whitepaper)20 Virtual Scientific Program (Press release, MEI Pharma, MAY 26, 2020, View Source [SID1234558453]). The event will include a review of the ME-401 program, the recent data presented at ASCO (Free ASCO Whitepaper)20, and commentary from key opinion leader Matthew J. Matasar, M.D., a board-certified medical oncologist/hematologist and Attending Physician, Lymphoma Service, and Medical Director, Memorial Sloan Kettering – Bergen.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Video Webcast Information

You can access the live video webcast under the investor relations section of MEI’s website on the "Events and Presentation" page at: www.meipharma.com. A replay of the video webcast will be archived for at least 30 days after the conclusion of the live event.